Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Valeant Pharmaceuticals International- Inc. (VRX)

23.4 -0.83 (-3.43%)

07-13 15:59

Open:

24.15

Pre. Close:

24.23

High:

24.43

Low:

23.365

Volume:

6,571,593

Market Cap:

8174M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

23.308 - 23.454

23.454 - 23.556

Low:

22.256 - 22.437

22.437 - 22.565

Close:

22.859 - 23.128

23.128 - 23.317

Technical analysis  (as of: 2018-07-19 2:27:05 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 30.13     One year: 32.46

Support:

Support1: 22.56    Support2: 18.77

Resistance:

Resistance1: 25.79    Resistance2: 27.79

Pivot:

23.29

Moving Averages:

MA(5): 23.50     MA(20): 23.52

MA(100): 19.84     MA(250): 17.86

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.13

%K %D:

%K(14,3): 32.66     %D(3): 44.80

RSI:

RSI(14): 46.25

52-Week:

High: 27.79  Low: 10.94  Change(%): 33.5

Average Vol(K):

3-Month: 820815  10-Days 476167

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
VRX has closed above bottom band by 32.9%. Bollinger Bands are 60.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to VRX's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-07-13T14:33:34-04:00
Summer Screens And Shorts Coming Out

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

348.71

Shares Float (M)

348.71

% Held by Insiders

2.00

% Held by Institutions

47.60

Shares Short (K)

14620

Shares Short Prior Month (K)

Stock Financials

EPS

3.960

EPS Est. Current Year

3.890

EPS Est. Next Year

3.520

EPS Est. Next Quarter

0.930

Forward EPS

3.387

Book Value (p.s.)

1.910

PEG Ratio

3.28

Profit Margin

-13.99

Operating Margin

5.01

Return on Assets (ttm)

-2.3

Return on Equity (ttm)

-22.0

Qtrly Rev. Growth

-5.4

Gross Profit (p.s.)

9.025

Sales Per Share

EBITDA (p.s.)

4.706

Qtrly Earnings Growth

Operating Cash Flow (M)

1770.00

Levered Free Cash Flow (M)

2520.00

atoplab.com

Valuation

P/E

5.82

P/E Growth Ratio

P/BV

12.06

P/S

327406560.00

P/CF

4.54

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2010-12-22

Ex-Dividend Date

2010-11-10

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.